These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 26884712

  • 21. Discovery of cell-permeable inhibitors that target the BRCT domain of BRCA1 protein by using a small-molecule microarray.
    Na Z, Pan S, Uttamchandani M, Yao SQ.
    Angew Chem Int Ed Engl; 2014 Aug 04; 53(32):8421-6. PubMed ID: 24961672
    [Abstract] [Full Text] [Related]

  • 22. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?
    Mark WY, Liao JC, Lu Y, Ayed A, Laister R, Szymczyna B, Chakrabartty A, Arrowsmith CH.
    J Mol Biol; 2005 Jan 14; 345(2):275-87. PubMed ID: 15571721
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31.
    Chappell WH, Gautam D, Ok ST, Johnson BA, Anacker DC, Moody CA.
    J Virol; 2015 Dec 23; 90(5):2639-52. PubMed ID: 26699641
    [Abstract] [Full Text] [Related]

  • 25. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
    Zhang X, Moréra S, Bates PA, Whitehead PC, Coffer AI, Hainbucher K, Nash RA, Sternberg MJ, Lindahl T, Freemont PS.
    EMBO J; 1998 Nov 02; 17(21):6404-11. PubMed ID: 9799248
    [Abstract] [Full Text] [Related]

  • 26. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.
    Zhuang J, Zhang J, Willers H, Wang H, Chung JH, van Gent DC, Hallahan DE, Powell SN, Xia F.
    Cancer Res; 2006 Feb 01; 66(3):1401-8. PubMed ID: 16452195
    [Abstract] [Full Text] [Related]

  • 27. Crystal structure of the N-terminal region of human Topoisomerase IIβ binding protein 1.
    Huo YG, Bai L, Xu M, Jiang T.
    Biochem Biophys Res Commun; 2010 Oct 22; 401(3):401-5. PubMed ID: 20858457
    [Abstract] [Full Text] [Related]

  • 28. BRCA1 participates in DNA decatenation.
    Lou Z, Minter-Dykhouse K, Chen J.
    Nat Struct Mol Biol; 2005 Jul 22; 12(7):589-93. PubMed ID: 15965487
    [Abstract] [Full Text] [Related]

  • 29. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
    Drikos I, Nounesis G, Vorgias CE.
    Proteins; 2009 Nov 01; 77(2):464-76. PubMed ID: 19452558
    [Abstract] [Full Text] [Related]

  • 30. Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining.
    Beckta JM, Dever SM, Gnawali N, Khalil A, Sule A, Golding SE, Rosenberg E, Narayanan A, Kehn-Hall K, Xu B, Povirk LF, Valerie K.
    Oncotarget; 2015 Sep 29; 6(29):27674-87. PubMed ID: 26320175
    [Abstract] [Full Text] [Related]

  • 31. Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint.
    Yamane K, Chen J, Kinsella TJ.
    Cancer Res; 2003 Jun 15; 63(12):3049-53. PubMed ID: 12810625
    [Abstract] [Full Text] [Related]

  • 32. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
    Pyrpassopoulos S, Ladopoulou A, Vlassi M, Papanikolau Y, Vorgias CE, Yannoukakos D, Nounesis G.
    Biophys Chem; 2005 Apr 01; 114(1):1-12. PubMed ID: 15792855
    [Abstract] [Full Text] [Related]

  • 33. BRCA1 haploinsufficiency for replication stress suppression in primary cells.
    Pathania S, Bade S, Le Guillou M, Burke K, Reed R, Bowman-Colin C, Su Y, Ting DT, Polyak K, Richardson AL, Feunteun J, Garber JE, Livingston DM.
    Nat Commun; 2014 Nov 17; 5():5496. PubMed ID: 25400221
    [Abstract] [Full Text] [Related]

  • 34. Assaying for Radioresistant DNA Synthesis, the Hallmark Feature of the Intra-S-Phase Checkpoint Using a DNA Fiber Technique.
    Kijas AW, Lavin MF.
    Methods Mol Biol; 2017 Nov 17; 1599():13-23. PubMed ID: 28477108
    [Abstract] [Full Text] [Related]

  • 35. A novel model to characterize structure and function of BRCA1.
    Lin D, Izadpanah R, Braun SE, Alt E.
    Cell Biol Int; 2018 Jan 17; 42(1):34-44. PubMed ID: 28833843
    [Abstract] [Full Text] [Related]

  • 36. A functional comparison of BRCA1 C-terminal domains in transcription activation and chromatin remodeling.
    Miyake T, Hu YF, Yu DS, Li R.
    J Biol Chem; 2000 Dec 22; 275(51):40169-73. PubMed ID: 11016938
    [Abstract] [Full Text] [Related]

  • 37. Structure of the DNA-bound BRCA1 C-terminal region from human replication factor C p140 and model of the protein-DNA complex.
    Kobayashi M, Ab E, Bonvin AMJJ, Siegal G.
    J Biol Chem; 2010 Mar 26; 285(13):10087-10097. PubMed ID: 20081198
    [Abstract] [Full Text] [Related]

  • 38. Strong preference of BRCA1 protein to topologically constrained non-B DNA structures.
    Brázda V, Hároníková L, Liao JC, Fridrichová H, Jagelská EB.
    BMC Mol Biol; 2016 Jun 08; 17(1):14. PubMed ID: 27277344
    [Abstract] [Full Text] [Related]

  • 39. BRCA1 and Its Network of Interacting Partners.
    Christou CM, Kyriacou K.
    Biology (Basel); 2013 Jan 02; 2(1):40-63. PubMed ID: 24832651
    [Abstract] [Full Text] [Related]

  • 40. Functional analysis of BRCA1 RING domain variants: computationally derived structural data can improve upon experimental features for training predictive models.
    Masso M.
    Integr Biol (Camb); 2020 Sep 30; 12(9):233-239. PubMed ID: 32984879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.